Evidence map›Paper›PMID 40322725›Full record

ArticleNeuropsychiatric disease and treatment2025

Potential Inflammatory Biomarkers and Differential Gut Microbiota in Cognitive Impairment After Ischemic Stroke.

Lishuo Wu, Yajie Jiang, Wei Xu, Liwen Wang, Liping Li, Chunli Zhang, Keyu Huang, Yi Yang, Jian Dai, Fengkun Zhou

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Blood-Based Biomarkers for Post-Stroke Cognitive Impairment.Current issues in molecular biology · 2026
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lishuo Wu *Department of Neurology, The First People's Hospital of Nanning, Nanning, Guangxi, People's Republic of China.
Yajie Jiang *Engineering Research Center of Innovative Traditional Chinese, Zhuang and Yao Materia Medica, Ministry of Education, Guangxi University of Chinese Medicine, Nanning, Guangxi, People's Republic of China.
Wei XuDepartment of Psychological and Sleep Rehabilitation,Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Liwen WangDepartment of Psychological and Sleep Rehabilitation,Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Liping LiDepartment of Psychological and Sleep Rehabilitation,Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Chunli ZhangDepartment of Neurology, The First People's Hospital of Nanning, Nanning, Guangxi, People's Republic of China.
Keyu HuangDepartment of Neurology, The First People's Hospital of Nanning, Nanning, Guangxi, People's Republic of China.
Yi YangDepartment of Psychological and Sleep Rehabilitation,Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Jian DaiDepartment of Psychological and Sleep Rehabilitation,Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Fengkun ZhouDepartment of Neurology, The First People's Hospital of Nanning, Nanning, Guangxi, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Ischemic stroke, one of the main public health problems worldwide, causes a variety of physiological dysfunction, including cognitive impairment. Although studies have been focused on posted-stroke cognitive impairment (PSCI), its pathological mechanism remains unclear. Methods: Here, we enrolled 66 participants stratified into three groups: healthy controls (HC, n=15), post-stroke patients without cognitive impairment (PSWCI, n=15), and PSCI patients (n=36). We analyzed clinical parameters and changes of several cytokines and gut microbiota profiles. Results: We found that compared with healthy control (HC) group, levels of low-density lipoprotein (LDL) cholesterol, total cholesterol (TC), homocysteine (Hcy), CRP and IL-6 were significantly increased in PSWCI and PSCI patients. Of them, levels of Hcy and IL-6 in PSCI group were significantly higher than that in PSWCI. ROC curve analysis identified Hcy and IL-6 as potential diagnostic biomarkers for PSCI. Furthermore, 16S rRNA sequencing of gut microbiota shows that the abundance of Conclusion: These findings suggest that elevated Hcy and IL-6 levels may serve as risk factors for PSCI, with gut microbiota dysregulation potentially contributing to its pathogenesis.

Indexed as

diagnostic efficacygut microbiotahomocysteineIL-6post-stroke cognitive impairment

Identifiers

PMID40322725
PMCPMC12047652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.